Related references
Note: Only part of the references are listed.Advanced diagnosis of polycystic ovary syndrome-new prediction models with standard parameters
Thomas Strowitzki
FERTILITY AND STERILITY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome
Jessica K. Devin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial
Yujing Li et al.
FERTILITY AND STERILITY (2020)
The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yuanyuan Guan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Factors associated with improvement in waist-to-height ratio among newly diagnosed type 2 diabetes patients treated with acarbose or metformin: A randomized clinical trial study
Lu-Lu Song et al.
WORLD JOURNAL OF DIABETES (2020)
A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
Mohammed Altigani Abdalla et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2020)
Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study
Shilpa Lingaiah et al.
FERTILITY AND STERILITY (2019)
Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome
Behnam Heidari et al.
MAYO CLINIC PROCEEDINGS (2019)
DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY
Simona Ferjan et al.
ENDOCRINE PRACTICE (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
Maria Othelie Underdal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
Tao Tao et al.
BMC ENDOCRINE DISORDERS (2018)
Effect of Orlistat Versus Metformin in Various Aspects of Polycystic Ovarian Syndrome: A Systematic Review of Randomized Control Trials
Soumya Ranjan Panda et al.
JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2018)
Cabell's Blacklist: A New Way to Tackle Predatory Journals
Soumitra Das et al.
INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE (2018)
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study
Karen E. Elkind-Hirsch et al.
FERTILITY AND STERILITY (2017)
Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study
Simona Ferjan et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2017)
Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
Mojca Jensterle et al.
BMC ENDOCRINE DISORDERS (2017)
Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
Elena Filipova et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome
Xin Liu et al.
CLINICAL ENDOCRINOLOGY (2017)
Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
Yifeng Xu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome
M. Nemati et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2017)
Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment
Feifei Cheng et al.
CLINICAL ENDOCRINOLOGY (2016)
A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome
Forough Javanmanesh et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Insulin is an important risk factor of endometrial cancer among premenopausal women: a case-control study in China
Yanli Shao et al.
TUMOR BIOLOGY (2016)
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes A Systematic Review and Meta-analysis
Nisa M. Maruthur et al.
ANNALS OF INTERNAL MEDICINE (2016)
Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis
S. K. Graff et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2016)
Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
Hatav Ghasemi-Tehrani et al.
Journal of Research in Medical Sciences (2016)
Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome
Zhihua Chen et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2016)
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
Negar Naderpoor et al.
HUMAN REPRODUCTION UPDATE (2015)
A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
Mojca Jensterle et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2015)
Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial
Ashraf Moini et al.
ENDOCRINE (2015)
Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
Mojca Jensterle Sever et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin
Rokhsareh Aghili et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2014)
Metformin decreases serum 8-hydroxy-2′-deoxyguanosine levels in polycystic ovary syndrome
Henri Sova et al.
FERTILITY AND STERILITY (2013)
Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone
Ozgul Muneyyirci-Delale et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
Mohd Ashraf Ganie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
Johanna Puurunen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome
L. Mohiyiddeen et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome
Qiang Du et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
The Role of Obesity in the Development of Polycystic Ovary Syndrome
Alicia Beatriz Motta
CURRENT PHARMACEUTICAL DESIGN (2012)
Insulin resistance: A significant risk factor of endometrial cancer
Nan Mu et al.
GYNECOLOGIC ONCOLOGY (2012)
Metformin Improves Pregnancy and Live-Birth Rates in Women with Polycystic Ovary Syndrome (PCOS): A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
Laure Morin-Papunen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
Jose Gomes Batista et al.
CLINICS (2012)
Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism
S. Morteza Taghavi et al.
DIABETES & VASCULAR DISEASE RESEARCH (2011)
Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study
Katerina K. Naka et al.
FERTILITY AND STERILITY (2011)
The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome-a double-blind randomized placebo-controlled study
Po Mui Lam et al.
FERTILITY AND STERILITY (2011)
The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study
Sedigheh Ghandi et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2011)
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Mark O. Goodarzi et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
H. Teede et al.
BMC MEDICINE (2010)
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial
Daniela Romualdi et al.
FERTILITY AND STERILITY (2010)
Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study
Birgitta Trolle et al.
FERTILITY AND STERILITY (2010)
Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study
Talieh Kazerooni et al.
FERTILITY AND STERILITY (2010)
Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study
Aida Hanjalic-Beck et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
L. W. Cho et al.
CLINICAL ENDOCRINOLOGY (2009)
The Effects of Rosiglitazone, Metformin, and Estradiol-Cyproterone Acetate on Lean Patients With Polycystic Ovary Syndrome
Sevki Cetinkalp et al.
ENDOCRINOLOGIST (2009)
Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
Vanita R. Aroda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study
Thozhukat Sathyapalan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
Mojca Jensterle et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome
Mojca Jensterle et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
Karen Elkind-Hirsch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Dorte Glintborg et al.
DIABETES CARE (2008)
Comparison of metabolic effects of metformin and rosiglitazone in the management of polycystic ovary syndrome (PCOS): A prospective, parallel, randomized, open-label study
Jamal Ahmad et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2008)
Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome
Stefano Palomba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome
Richard S. Legro et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome
Evanthia Diamanti-Kandarakis et al.
CLINICAL ENDOCRINOLOGY (2007)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
Dorte Glintborg et al.
FERTILITY AND STERILITY (2006)
The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome - a randomised, double-blind, placebo-controlled trial
J. Lord et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study
K. Rautio et al.
HUMAN REPRODUCTION (2006)
Early effects of metformin in women with polycystic ovary syndrome: A prospective randomized, double-blind, placebo-controlled trial
S Eisenhardt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
NA Cataldo et al.
HUMAN REPRODUCTION (2006)
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome
D Glintborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome
M Yilmaz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2005)
Acarbose in obese patients with polycystic ovarian syndrome:: a double-blind, randomized, placebo-controlled study
IAA Penna et al.
HUMAN REPRODUCTION (2005)
Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease
D Dereli et al.
ENDOCRINE JOURNAL (2005)
Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study
EB Kilicdag et al.
HUMAN REPRODUCTION (2005)
Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome
C Ortega-González et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
V Jayagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome
AS Sonmez et al.
HUMAN REPRODUCTION (2005)
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
A Gambineri et al.
CLINICAL ENDOCRINOLOGY (2004)
Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome
N Brettenthaler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women:: results of a randomized study
E Vanky et al.
HUMAN REPRODUCTION (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: A randomized, double-blind and placebo-controlled trial
KH Chou et al.
HORMONE AND METABOLIC RESEARCH (2003)
Obesity and the polycystic ovary syndrome
A Gambineri et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome:: a prospective randomized trial
H Yarali et al.
HUMAN REPRODUCTION (2002)
Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome
M Kocak et al.
FERTILITY AND STERILITY (2002)
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
L Ciotta et al.
HUMAN REPRODUCTION (2001)
Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial
EHY Ng et al.
HUMAN REPRODUCTION (2001)
Share Paper
